Uniwersytecki Szpital Kliniczny w Opolu
12
2
2
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
8.3%
1 terminated/withdrawn out of 12 trials
88.9%
+2.4% vs industry average
8%
1 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Superior Vena Cava Collapsibility Index for Predicting Fluid Responsiveness During High-risk Non-cardiac Surgery
Role: lead
Changes of Renal Resistive Index in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy.
Role: lead
Fluid Responsiveness Tests in Critically Ill Patients During Admission to the Intensive Care Unit
Role: lead
Vitamin D3 Supplementation in Critically Ill Patients Undergoing CRRT
Role: lead
Serum Vitamin D Levels in Critically Ill Patients Undergoing Regional Citrate Anticoagulation CRRT
Role: lead
Parathyroid Hormone Kinetics During CRRT
Role: lead
Ultrasound-guided Axillary Artery vs Femoral Artery Cannulation.
Role: lead
Ultrasound Guided Axillary Versus Jugular Central Venous Catheterization
Role: lead
Ultrasound Assessment of Changes in the Diameter of the Common Carotid Artery After Increasing the Preload of the Heart
Role: lead
Influence of Early vs Late SPN on Long-term Quality of Life in ICU Patients After Gastrointestinal Oncological Surgery
Role: collaborator
An Infraclavicular Landmark-based Approach to the Axillary Vein
Role: lead
Ultrasound-guided Catheterization of the Axillary Vein
Role: lead
All 12 trials loaded